ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 29 No. 6 | June 30, 2006

Download PDF Visit The Full Archive

Related Articles

US Oncology Clarifies Role of Pharmacy Committee

January 24, 2003

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

Guest Editorial: Nobel Laureates Offer Simple Formula To Save CPRIT From “Infamy and Irrelevance”

October 19, 2012

Michael Atkins Named Deputy Director at Georgetown Lombardi Cancer Center

March 2, 2012

Et2’s Referral Guidelines

July 23, 1993

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976